Skip to main content

Microbiome Labs launches EpicDefense on Amazon

By: Newsfile
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

A science-first challenge to traditional immune support, now available directly for consumers

Franklinton, North Carolina--(Newsfile Corp. - May 18, 2026) - Microbiome Labs™, a leader in microbiome-based solutions, announces the official launch of EpicDefense™ on Amazon, expanding consumer access to its latest microbiome-focused immune-support formula.

EpicDefense is formulated to support the body's natural defenses and promote respiratory comfort through a direct, science-first approach*. With this launch, Microbiome Labs is delivering a professional-grade immunobiotic formula that shifts the focus from reactive supplementation to proactive, gut-powered resilience.

The formula combines clinically studied strains selected to support respiratory health and immune balance, including:

  • LGG (Lacticaseibacillus rhamnosus GG): Clinically shown to support upper respiratory health and maintain immune balance.
  • BB-12 (Bifidobacterium animalis subsp. lactis): Documented to support natural antibody response to immune challenges.
  • EpiCor®: A whole-food yeast fermentate that supports healthy nasal airflow and respiratory comfort.
  • Zinc Bisglycinate (Albion® Minerals): A chelated form of zinc optimized for absorption to enhance Natural Killer cell functionality.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/11973/297372_microbiome1_550.jpg

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11973/297372_microbiome1.jpg

"For too long, immune support has focused on short-term reactions rather than building resilient systems," says Alicia Galvin, MEd, RD, LD, IFNCP, head of scientific affairs at Microbiome Labs. "EpicDefense reflects a shift toward proactive, gut-powered defense grounded in clinical science and made accessible without compromising rigor. This launch represents our commitment to translating validated microbiome research into real-world solutions."

EpicDefense is non-GMO, soy-free and dairy-free, meeting the rigorous standards healthcare practitioners and microbiome experts expect. To learn more about the company's mission to pioneer health, visit microbiomelabs.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

###

About Microbiome Labs
Microbiome Labs, part of Novonesis Human Health Biosolutions, provides innovative, research-based solutions that support the body's microbial ecosystem. With a focus on clinical application and practitioner partnerships, Microbiome Labs delivers evidence-informed products designed to support overall wellness. Learn more at microbiomelabs.com.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297372

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  264.86
+0.72 (0.27%)
AAPL  297.84
-2.39 (-0.80%)
AMD  420.99
-3.11 (-0.73%)
BAC  50.69
+0.92 (1.85%)
GOOG  393.11
-0.21 (-0.05%)
META  611.21
-3.02 (-0.49%)
MSFT  423.54
+1.62 (0.38%)
NVDA  222.32
-3.00 (-1.33%)
ORCL  186.61
-6.34 (-3.29%)
TSLA  409.99
-12.25 (-2.90%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.